Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$247M |
| 2 |
Johnson & Johnson
JNJ
|
+$225M |
| 3 |
MON
Monsanto Co
MON
|
+$213M |
| 4 |
AET
Aetna Inc
AET
|
+$208M |
| 5 |
Broadcom
AVGO
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$227M |
| 2 |
Microsoft
MSFT
|
+$224M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Nike
NKE
|
+$187M |
| 5 |
Pfizer
PFE
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.75% |
| 2 | Technology | 13.74% |
| 3 | Healthcare | 12.69% |
| 4 | Industrials | 11.51% |
| 5 | Consumer Discretionary | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Republic Services
RSG
$66B
| $11.6M | 0.02% |
+203,700
| New | +$10.9M |
|
1127
JB Hunt Transport Services
JBHT
$26.7B
| $11.6M | 0.02% |
119,544
-375,800
| -76% | -$33.4M |
|
|
JMEI
1128
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
| $11.5M | 0.02% |
229,480
+30,170
| +15% | +$1.51M |
|
|
GNCMA
1129
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $11.5M | 0.02% |
590,900
-69,500
| -11% | -$1.15M |
|
1130
Guidewire Software
GWRE
$14.4B
| $11.5M | 0.02% |
232,700
-169,600
| -42% | -$9.51M |
|
1131
Grupo Aeroportuario Centro Norte
OMAB
$5.11B
| $11.5M | 0.02% |
331,900
+121,200
| +58% | +$5.04M |
|
|
HAPN
1132
Happen Inc
HAPN
$2.28B
| $11.5M | 0.02% |
436,539
+152,919
| +54% | +$4.2M |
|
1133
Dawson Geophysical
DWSN
$112M
| $11.5M | 0.02% |
1,495,874
+55,860
| +4% | +$402K |
|
1134
Willdan Group
WLDN
$1.31B
| $11.5M | 0.02% |
506,989
+141,189
| +39% | +$2.87M |
|
|
ATCO
1135
DELISTED
Atlas Corp.
ATCO
| $11.5M | 0.02% |
1,253,000
+72,400
| +6% | +$767K |
|
1136
iShares 20+ Year Treasury Bond ETF
TLT
$40.6B
| $11.4M | 0.02% |
96,100
+61,500
| +178% | +$7.7M |
|
|
TA
1137
DELISTED
TravelCenters of America LLC
TA
| $11.4M | 0.02% |
322,360
-60
| -0% | -$2.03K |
|
1138
Aramark
ARMK
$16.4B
| $11.4M | 0.02% |
443,062
-115,370
| -21% | -$3.01M |
|
1139
Sumitomo Mitsui Financial
SMFG
$167B
| $11.4M | 0.02% |
1,492,100
-86,200
| -5% | -$626K |
|
1140
Enova International
ENVA
$6.58B
| $11.3M | 0.02% |
904,200
+464,400
| +106% | +$5.01M |
|
|
NBL
1141
DELISTED
Noble Energy, Inc.
NBL
| $11.3M | 0.02% |
298,077
+62,600
| +27% | +$2.33M |
|
1142
Ennis
EBF
$558M
| $11.3M | 0.02% |
651,600
-72,000
| -10% | -$1.17M |
|
|
JOY
1143
DELISTED
Joy Global Inc
JOY
| $11.3M | 0.02% |
403,425
-262,300
| -39% | -$7.33M |
|
1144
Choice Hotels
CHH
$4.72B
| $11.3M | 0.02% |
201,300
+172,100
| +589% | +$8.63M |
|
1145
Crane NXT
CXT
$2.95B
| $11.3M | 0.02% |
449,988
+278,112
| +162% | +$6.74M |
|
|
NSR
1146
DELISTED
Neustar Inc
NSR
| $11.3M | 0.02% |
337,400
+63,000
| +23% | +$1.67M |
|
1147
Ribbon Communications
RBBN
$374M
| $11.2M | 0.02% |
1,783,500
-122,689
| -6% | -$806K |
|
|
EMKR
1148
DELISTED
Emcore Corp
EMKR
| $11.2M | 0.02% |
129,110
-3,110
| -2% | -$214K |
|
|
KEM
1149
DELISTED
KEMET Corporation
KEM
| $11.2M | 0.02% |
1,694,001
+1,366,002
| +416% | +$6.54M |
|
|
AE
1150
DELISTED
Adams Resources & Energy Inc
AE
| $11.2M | 0.02% |
283,100
+2,900
| +1% | +$114K |
|
Similar funds
Jim Simons's Q4 2016 Portfolio in Review
As of Q4 2016, Jim Simons held 3,715 positions worth $63.2B, up 12% from $56.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Jim Simons deployed $5.07B of net new capital in Q4 2016, opening 418 new positions and adding to 1,792 existing holdings. Its largest new stake was Broadcom: 10,144,960 shares worth $179M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $227M trimmed.
- Jim Simons's largest Q4 2016 buy was Broadcom: 10,144,960 shares worth $179M.
- Jim Simons added most to Gilead Sciences in Q4 2016, an estimated $247M increase.
- Jim Simons's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $227M.
- Jim Simons fully exited Alphabet (Google) Class C in Q4 2016, selling an estimated $205M.
- Jim Simons's ten largest holdings make up 7.2% of its $63.2B portfolio in Q4 2016.
- Jim Simons opened 418 new positions and closed 494 in Q4 2016.
- Jim Simons's portfolio value rose 12% quarter-over-quarter to $63.2B.
Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.